免费获取“合成生物学行业报告”！技术路径、产业布局与投资逻辑等全解（可获取PDF全文）

Core Insights - The report titled "Synthetic Biology Industry & Investment Strategy Research Report" provides a comprehensive analysis of the synthetic biology sector, covering technical pathways, market landscape, representative companies, industrial clusters, and policy trends [2]. Group 1: Company Overview - Zhejiang Jintou Shengyuan Equity Investment Co., Ltd. was established in June 2023 with a registered capital of 200 million yuan, serving as a market-oriented equity investment platform under the Zhejiang Provincial Innovation Investment Group [6]. - The company focuses on sectors such as new materials, new technologies, and biomedicine, with a total fund scale exceeding 10 billion yuan [6][34]. - Jintou Shengyuan aims to enhance the operational efficiency of provincial government industrial funds and contribute to the modernization of the industrial system in Zhejiang [34]. Group 2: Market Dynamics - The global synthetic biology market has grown from $5.3 billion in 2018 to over $17 billion in 2023, with an average annual growth rate of 27% [25]. - The Chinese market is projected to reach approximately 10 billion yuan in 2024 and continue to grow to 12.406 billion yuan in 2025 [25]. - The report highlights the importance of technological pathways and the challenges in scaling synthetic biology applications from laboratory to industrial levels [24][25]. Group 3: Key Companies and Financial Data - Shanghai Kasei Biotechnology Co., Ltd. reported revenues of 2.34 billion yuan, 2.68 billion yuan, and 3.21 billion yuan for 2023, 2024, and 2025 respectively, with profits of 580 million yuan, 650 million yuan, and 710 million yuan [7]. - Ginkgo Bioworks, established in 2008, has expanded its offerings into life science tools and services, leveraging AI and automation to enhance research efficiency [14][15]. Group 4: Technological Advancements - The report discusses significant technological milestones in synthetic biology, including the development of scalable production techniques for long-chain dicarboxylic acids and advancements in AI-driven manufacturing platforms [7][15]. - Key technological pathways include gene editing, synthetic biology techniques, and metabolic engineering, which are crucial for enhancing production efficiency and reducing costs [29].